Oakland, CA, United States of America

Amy K W Lasek

This inventor holds 1 USPTO granted patent. Top assignee: Incyte Genomics, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy K W Lasek. Retrieved from https://idiyas.com/inventor/amy-k-w-lasek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Amy K W Lasek

Introduction

Amy K W Lasek is a notable inventor based in Oakland, CA. He has made significant contributions to the field of cancer research through his innovative work on transmembrane proteins. His research focuses on the differential expression of these proteins in neoplastic disorders, which has important implications for diagnosis and treatment.

Latest Patents

Lasek holds a patent for a transmembrane protein that is differentially expressed in cancer. This invention provides a transmembrane protein that is specifically associated with neoplastic disorders. It also includes the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind to the protein. These elements can be utilized in various methods to diagnose, stage, treat, or monitor the treatment of neoplastic disorders. He has 1 patent to his name.

Career Highlights

Lasek is currently employed at Incyte Genomics, Inc., where he continues to advance his research in the field of oncology. His work is pivotal in understanding the molecular mechanisms of cancer and developing targeted therapies.

Collaborations

Some of his notable coworkers include Mariah R Baughn and Yalda Azimzai, who contribute to the collaborative efforts in their research projects.

Conclusion

Amy K W Lasek's innovative work in cancer research exemplifies the impact of transmembrane proteins in medical science. His contributions are vital for the advancement of diagnostic and therapeutic strategies in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…